PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,271,000 | -77.0% | 121,876 | +1.0% | 0.00% | -77.8% |
| Q3 2018 | $5,531,000 | -18.5% | 120,640 | +0.2% | 0.01% | -25.0% |
| Q2 2018 | $6,788,000 | -71.1% | 120,457 | -65.1% | 0.01% | -70.7% |
| Q1 2018 | $23,475,000 | -30.5% | 344,965 | +0.9% | 0.04% | -25.5% |
| Q4 2017 | $33,786,000 | -16.8% | 341,790 | -1.3% | 0.06% | -22.5% |
| Q3 2017 | $40,629,000 | +23.3% | 346,369 | -8.8% | 0.07% | +20.3% |
| Q2 2017 | $32,942,000 | -45.4% | 379,734 | -76.4% | 0.06% | +9.3% |
| Q1 2017 | $60,294,000 | +200.0% | 1,607,852 | +145.6% | 0.05% | +42.1% |
| Q4 2016 | $20,100,000 | – | 654,721 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |